Advent: EU approves acquisition of Baxter Pharma Solutions

(CercleFinance.com) - The European Commission has cleared the acquisition of joint control of Baxter Pharmaceutical Solutions LLC of the US and Baxter Oncology GmbH of Germany ("BPS") by Advent International Corporation and its affiliated funds ("Advent") and Warburg Pincus LLC and its affiliated funds ("Warburg Pincus"), both of which are from the US.


BPS provides contract development and manufacturing organization services for finished dose pharmaceutical products.

Advent is a private equity investor specializing in acquiring interests and managing investment funds in various sectors, including healthcare.

Warburg Pincus is a global private equity firm active in various sectors, including healthcare.

The Commission concluded that the proposed acquisition would not give rise to any competition concerns, given the companies' limited combined market position and the limited vertical relations resulting from the proposed transaction.


Copyright (c) 2023 CercleFinance.com. All rights reserved.